by Elme r M. Cranton, M.D.

Intravenous edta chelation therapy, a simple office procedure using ethylene diamine
tetraacetic acid (EDTA), reverses and slows progression of atherosclerotic heart
disease, hardening of the arteries, and other age-related and degenerative diseases.
Symptoms affecting many different parts of the body often improve, for reasons that
are not yet fully understood. Blood flow increases in blocked coro nary arteries to the
heart, to the brain, to the legs, and all throughout the body. Heart attacks, strokes, leg
pain and gangrene can often be helped or avoided using this therapy. Need for bypass
surgery and balloon angioplasty often disappears after che lation. Published research
also shows that chelation therapy acts as a preventive against cancer.

The free radical theory of disease (caused by oxygen free radicals) provides one
scientific explanation for the many observed benefits following chelation therapy.
Many scientific studies published in peer reviewed medical journals provide solid
clinical evidence for benefit. This non-invasive therapy is very much safer and far less
expensive than surgery or angioplasty.

Chelation therapy is a safe and effective alternative to bypass surgery, angioplasty and
stents. Hardening of the arteries need not lead to coronary bypass surgery, heart
attack, amputation, stroke, or senility. There is new hope for victims of these and
other related diseases. Despite what you may have heard from other sources, EDTA
chelation therapy, administered by a properly trained practitioner, in conjunction with
a healthy lifestyle, prudent diet, and nutritional supplements, is an option to be
seriously considered by persons suffering from coronary artery disease, cerebral
vascular disease, brain disorders resulting from circulatory disturbances, generalized
hardening of the arteries (atherosclerosis, also called arteriosclerosis) and related
ailments which can lead to stroke, heart attack, senility, gangrene, and accelerated
physical decline.

Clinical benefits from chelation therapy vary with the total number of treatments
received and with severity of the condition being treated. On average, 85 percent of
chelation patients have improved very significantly. More than 90 percent of patients
receiving 30 or more chelation infusions have benefited enough to be grateful for this
therapy—even more so when they also followed a healthy lifestyle, avoiding the use
of tobacco. Symptoms improve, blood flow to diseased organs increases, need for
medication often decreases and, most importantly, the quality of life becomes more
productive and enjoyable.

When patients first hear about or consider EDTA chelation therapy, they normally
have lots of questions. Undoubtedly you do, too. Here are the answers to those most
commonly asked questions, explained in non-technical language.


                                         1 of 13
                                  7/6/2011 @8:47 PM
Chelation (pronounced KEY-LAY-SHUN) is the process by which a metal or mineral
(such as calcium, lead, cadmium, iron, arsenic, aluminum, etc.) is bonded to another
substance―in this case EDTA, an amino acid. It is a natural process, basic to life
itself. Chelation is one mechanism by which such common substances as aspirin,
antibiotics, vitamins, minerals and trace elements work in the body. Hemoglobin, the
red pigment in blood which carries oxygen, is a chelate of iron.


Chelation is a treatment by which a small amino acid called ethylene diamine
tetraacetic acid (commonly abbreviated EDTA) is slowly administered to a patient
intravenously over several hours, prescribed by and under the supervision of a
licensed health care practitioner. The IV fluid containing EDTA is infused through a
small needle placed in the vein of a patient’s arm. The EDTA infusion bonds with
unbalanced metals in the body and quickly redistributes them in a healthy way, or
carries them away in the urine. Abnormally situated nutritional metals, such as iron,
along with toxic elements such as lead, mercury and aluminum are easily removed by
EDTA chelation therapy. Normally present minerals and trace elements which are
essential for health are more tightly bound within the body and can be maintained
with a properly balanced nutritional supplement.


On the contrary, chelation therapy usually consists of anywhere from 20 to 50
separate infusions, depending on each patient’s individual health status. Thirty
treatments is the average number required for optimum benefit in patients with
symptoms of arterial blockage. Some patients eventually receive more than 100
chelation therapy infusions over several years. Other healthier patients receive only 20
infusions as part of a preventive program. Each chelation treatment takes three hours
or longer and patients cannot receive more than one treatment each day. It is the total
number of treatments that determine results, not the schedule or frequency. Some
patients receive treatments daily and others come weekly or at at variable intervals as
convenience and their schedule dictates. Over a period of time, these injections halt
the progress of the free radical disease. Free radicals underlie the development of
atherosclerosis and many other degenerative diseases of aging. Reduction of
damaging free radicals it believed to allow diseased arteries to heal, restoring blood
flow. With time chelation therapy brings profound improvement to many essential
metabolic and physiologic functions in the body. The body’s regulation of calcium
and cholesterol is restored by normalizing the internal chemistry of cells. Chelation
has many favorable actions on the body.

Chelation therapy benefits the flow of blood through every vessel in the body, from
the largest to the tiniest capillaries and arterioles, most of which are far too small for
surgical treatment or are deep within the brain where they cannot be safely reached by
surgery. In many patients, the smaller blood vessels are the most severely diseased,
especially in the presence of diabetes. The benefits of chelation occur simultaneously
from the top of the head to the bottom of the feet, not just in short segments of a few
large arteries which can be bypassed by surgical treatment.

                                         2 of 13
                                  7/6/2011 @8:47 PM

No, chelation therapy is an out-patient treatment available in a physician’s office or


Being "chelated" is quite a different experience from other medical treatments. There

is no                                  pain, and in most cases, very little discomfort.
Patients are seated in reclining chairs and can read, nap, watch TV, do needlework, or
chat with other patients while the fluid containing the EDTA flows into their veins. If
necessary, patients can walk around. They can visit the restroom, eat and drink as they
desire, or make telephone calls, being careful not to dislodge the needle attached to
the intravenous infusion they carry with them. Some patients even run their businesses
by telephone or computer while receiving chelation therapy.


EDTA chelation therapy is relatively non-toxic and risk- free, especially when
compared with other treatments. Patients routinely drive themselves home after
chelation treatment with no difficulty. The risk of significant side effects, when
properly administered, is less than 1 in 10,000 patients treated. By compariso n, the
overall death rate as a direct result of bypass surgery is approximately 3 out of every
100 patients, varying with the hospital and the operating team. The incidence of other
serious complications following surgery is much higher, approaching 25%, including
heart attacks, strokes, blood clots, mental impairment, infection, and prolonged pain.
Chelation therapy is at least 300 times safer than bypass surgery.

Occasionally, patients may suffer minor discomfort at the site where the needle enters
the vein. Some temporarily experience mild nausea, dizziness, or headache as an
immediate aftermath of treatment, but in the vast majority of cases, these minor
symptoms are easily relieved. When properly administered by a trained health care
practitioner expert in this type of therapy, chelation is safer than many other
prescription medicines. Statistically speaking, the treatment itself is safer than the
drive in an automobile to the doctors office.

If EDTA chelation therapy is given too rapidly or in too large a dose it may cause
harmful side effects, just as an overdose of any other medicine can be dangerous.
Reports of serious and even rare fatal complications many years ago stemmed from
excessive doses of EDTA, administered too rapidly and without proper laboratory

                                         3 of 13
                                  7/6/2011 @8:47 PM
monitoring. If you choose a provider with proper training and experience, who is an
expert in the use of EDTA, the risk of chelation therapy will be kept to a very low

While it has been stated by critics that EDTA chelation therapy is damaging to the
kidneys, the newest research (consisting of kidney function tests done on hundreds of
consecutive chelation patients, before and after treatment with EDTA for chronic
degenerative diseases) indicates the reverse is true. There is, on the avera ge,
significant improvement in kidney function following chelation therapy. An
occasional patient may be unduly sensitive, however, and practitioners expert in
chelation monitor kidney function with laboratory testing to avoid overloading the
kidneys. Chelation treatments must be given more slowly and less frequently if kidney
function is not normal. Patients with some types of severe kidney problems should not
receive EDTA chelation therapy.


Prior to commencing a course of chelation therapy a complete medical history is
obtained. Diet is analyzed for nutritional adequacy and balance. Copies of pertinent
medical records and summaries of hospital admissions may be sent for. A thorough
head-to-toe, hands-on physical examination will be performed. A complete list of
current medications will be recorded, including the time and strength of each dose.
Special note will be made of any allergies.

Blood and urine specimens will be obtained in a battery of tests to insure that no
conditions exist which should be treated differently or might be worsened by
chelation therapy. Kidney function will be carefully assessed. An electrocardiogram is
usually obtained. Noninvasive tests will be performed, as medically indicated, to
determine the status of arterial blood flow prior to therapy. A consultation with other
medical specialists may be requested.


Not at all. Chelation's earliest application with humans was before World War II when
the British used another chelating agent, British Anti- Lewesite (BAL), as a poison gas
antidote. BAL is related to chelators still used today in medicine.

EDTA was first introduced into medicine in the United States in 1948 as a treatment
for industrial workers suffering from lead poisoning in a battery factory. Shortly
thereafter, the U.S. Navy advocated chelation therapy for sailors who had absorbed
lead while painting government ships and dock facilities. In the years since, chelation
therapy has remained the undisputed treatment-of-choice for lead poisoning, even in
children with toxic accumulations of lead in their bodies as a result of eating leaded
paint from toys, cribs or walls.

In the early 1950’s it was speculated that EDTA chelation therapy might help the
accumulations of calcium associated with hardening of the arteries. Experiments were
performed and victims of atherosclerosis experienced health improvements following
chelation—diminished angina, better memory, sight, hearing and increased vigor. A

                                        4 of 13
                                 7/6/2011 @8:47 PM
number of practitioners then began to routinely treat individuals suffering from
occlusive vascular conditions with chelation therapy. Consistent improvements were
reported for most patients.

Published articles describing successful treatment of atherosclerosis with EDTA
chelation therapy first appeared in medical journals in 1955. Dozens of favorable
articles have been published since then. No unsuccessful results have ever been
reported (with the exception of several recent studies with very flawed data
deceptively presented by bypass surgeons, in a seeming attempt to discredit this
competing therapy). There have also been a number of editorial comments of a critical
nature made by physicians with vested interests in vasc ular surgery and related

From 1964 on, despite continued documentation of its benefits and the development
of safer treatment methods, the use of chelation for the treatment of arterial disease
has been the subject of controversy.


Absolutely. There is no legal prohibition against a licensed medical doctor using
chelation therapy for whatever conditions he or she deems it to be in the best interests
of their patients, even though the drug involved, EDTA, does not yet have
atherosclerosis listed as an indication on the FDA-approved package insert. Contrary
to popular belief, the FDA does not regulate the practice of medicine, but merely
approves marketing, labeling and advertising claims for drugs and devices sold in
interstate commerce.

It costs many millions of dollars to perform the required research and to provide the
FDA with documentation for a new drug claim, or even to add a new use to marketing
brochures of a long established medicine like EDTA. Physicians routinely prescr ibe
medicines for conditions not included on FDA approved advertising and marketing

The American College for Advancement in Medicine conducts educational courses in
the proper and safe use of intravenous EDTA chelation twice yearly. They also
publish a Protocol which contains professionally recognized standards of medical
practice for chelation therapy.

On the question of legality, courts have expressed the opinion that a practitioner who
withholds information about the availability of other treatment choices, such as
chelation therapy, prior to performing vascular surgery (along with all other treatment
modalities) is in violation of the doctrine of informed consent. Withholding
information about a form of treatment may be tantamount to medical malpractice, if
as a result, a patient is deprived of possible benefit. Thus, it is the doctors who refuse
to recognize and inform their patients about chelation who are risking legal liability—
not those chelating practitioners informed enough to resist peer pressure and provide
an innovative treatment which they feel to be the safest, the most effective and the
least expensive for many of their patients.

                                         5 of 13
                                  7/6/2011 @8:47 PM

Practitioners with extensive experience in the use of chelation therapy observe
dramatic improvement in the vast majority of their patients. They see angina routinely
relieved; patients who suffered searing chest and leg pain when walking only a short
distance are frequently able to return to normal, productive living after undergoing
chelation therapy. Far more dramatic, but equally common, is seeing diabetic ulcers
and gangrenous feet clear up in a matter of weeks. Individuals who have been told
that their limbs would need to be amputated because of gangrene are thrilled to watch
their feet heal with chelation therapy, although some areas of dead tissue may still
have to be trimmed away surgically.

The approximately 1,500 American practitioners practicing chelation therapy, plus
hundreds of others in foreign countries, have countless case histories to prove they are
able to reverse serious cases of arterial disease. Men and women often arrive at
doctors’ offices near death with diseases caused by blocked arteries. Weeks or months
later, they’re remarkably improved. There is a wealth of evidence from clinical
experience that symptoms of reduced blood flow improve in up to 85 percent o f
patients treated. More than a million patients have thus far received chelation therapy,
almost as many as have undergone bypass surgery.

All clinical trials of chelation therapy have been positive. There are no negative data,
although a few report had a deceptively negative spin on positive data. In addition,
several research studies have been published with results of before-and-after
diagnostic tests using radio- isotopes and ultra sound which prove statistically that
blood flow increases following chelation therapy. Even without blood-flow studies, if
leg pain on walking is relieved, if angina becomes less bothersome, and if p hysical
endurance and mental acuity improve, such benefits would be quite enough to justify
EDTA chelation therapy. Improved quality of life and relief of symptoms are the most
important benefits of chelation therapy.


Coronary artery bypass surgery, the popularly-prescribed procedure in which blocked
portions of major coronary arteries of the heart are bypassed with grafts from a
patient’s leg veins, has never been proven by properly controlled studies to offer
much or an advantage over non-surgical treatments, other that relief of pain in a
minority of patients who cannot be controlled with medicine. It has even been
suggested that the relief of pain following surgery might result from the cutting of
nerve fibers which carry pain impulses from the heart and which also stimulate spasm
of coronary arteries. It is not possible to perform bypass surgery without interrupting
those nerves.

Arteriograms which are done to x-ray and visualize the arteries prior to surgery utilize
a chemical dye which can cause arterial spasm. It is difficult to determine on the x-
rays how much arterial blockage is permanent and how much is reversible spasm. It is
common practice during angiograms to inject medication that amplifies the effects of
diseased coronary arteries.

                                        6 of 13
                                 7/6/2011 @8:47 PM
Indeed, the most recent research suggests that many of the more than 200,000
bypasses performed each year for the relief of pain and other symptoms brought on by
clogged or blocked arteries are not necessary. A good case against rushing into bypass
surgery is made by the findings of a ten- year, $24- million study conducted by the
National Institutes of Health (NIH) which compared post-operative survival rates of
"bypassed" patients with a matched group of equally diseased patients treated non-

The study uncovered no advantage for the majority of patients who had been operated
upon, compared with those receiving non-surgical therapy. It is important to note that
the non-surgical therapy reported in that study did not include either chelation therapy
or the newer calcium blocker drugs, and that only half of the patients received beta
blocker drugs. Although studies have been reported to show that patients with left
main coronary artery blockage live slightly longer after surgery, the studies were done
before calcium blockers and newer beta blockers were available. Those medicines
have been scientifically proven to protect against heart attack. Surgery might have
come out a clear second best if all presently available non-surgical treatments,
including chelation, had been compared to bypass.

Having surgery didn’t improve the chances for most patients to live longer, live
healthier, live better, or enjoy life more , when the results were statistically analyzed.
The incidence of heart attacks (myocardial infarction) and both employment and
recreational status were the same when comparing a large group of patients treated
surgically with those treated non-surgically, even without using chelation therapy for
the non-surgical treatment group.

Most importantly, cardiovascular surgery does nothing to arrest or reverse the
underlying disease, which exists in varying degrees throughout the body. It is at best a
piecemeal "cure" for a system- wide problem. Bypassing a tiny portion of the body’s
blood vessels can have little lasting benefit when the same degenerating condition
which caused the most extreme blockage at one or two sites must of necessity be
taking place everywhere, throughout the circulatory network.

One thing the general public is not fully aware of is that many people who have one
bypass operation later need a second bypass. Sometimes the blood vessels that
weren’t bypassed become clogged and also need bypassing; sometimes the
transplanted vessels used in the first graft become filled with new plaque; not
uncommonly, the transplants malfunction or turn out to be too small for the job. As a
matter of fact, studies have shown that by ten years after surgery, grafted vessels had
closed in 40 percent of patients, and in the remaining 60 percent, half developed
further coronary narrowing. Once you’ve had a bypass, your chances of being referred
for another go up about five percent a year. After five years, some surgical spec ialists
estimate, your need for a second operation could be as high as 30 to 40 percent. And
some patients go on to even a third operation or more. And approximately 2 to 3 out
of every 100 patients undergoing bypass surgery die as a result of the procedure—
even more if they are severely ill at the time of surgery. A much larger percentage
suffer serious complications, even after they survive the surgery. Those percentages
are similar for balloon angioplasty—with or without stents.

Chelation patients are frequently able to return to work and to resume their sports and

                                         7 of 13
                                  7/6/2011 @8:47 PM
other activities, without the need to undergo surgery. If they stay on a proper diet,
exercise within limits of tolerance, continue to take the prescribed program of
nutritional supplements, and receive periodic maintenance chelation treatments (every
one to two months, depending on the severity of the underlying medical diagnosis)
they can usually go many years without suffering further heart attacks, strokes,
senility or gangrenous extremities.

If you have been told, like most people eager for additional information about
chelation therapy, that you have advanced arterial disease, you may have been advised
to have vascular surgery or balloon angioplasty. If so, it is essential for you to
understand the nature of your disease and all possible treatment choices, before you
can make an intelligent decision concerning the various options. Even if chelation
therapy and other non-surgical therapies should fail, bypass still remains a choice.
Although bypass can relieve symptoms, as a last resort, surgery does not prevent heart
attacks or prolong live in the vast majority of patients operated.


Chelation therapy is gaining recognition so rapidly that there is growing interest in
developing an oral chelator that will produce benefits similar to intravenous EDTA
chelation therapy. Many nutritional substances administered by mouth are known to
have chelating properties but none have the spectrum of activity of intravenous
EDTA. Many nutrients such as vitamin C and the amino acids cysteine and aspartic
acid have the ability to weakly chelate metals. They also protect against free radical
damage in other ways, as anti-oxidants.

Claims are being increasingly made for the use of nutritional supplements containing
weak chelators in patients with atherosclerosis. There is nothing new about these
products which are mostly vitamins and minerals being aggressively marketed with
glowing testimonials and deceptive marketing techniques. Benefit from products
taken by mouth has never even come close to the much more dramatic results seen
with intravenous EDTA.

Recently some nutritional supplements which contain EDTA have been alleged to be
effective as oral chelation therapy. The problem is that only 5 percent or less of
EDTA is absorbed by mouth. The same tiny percentage applies to rectal suppositories.
The remainder passes out in the stool. And, it must be taken every day by mouth to
absorb even a small amount. When taken on a daily basis, oral EDTA binds essential
nutrients in the digestive tract and blocks their absorption, causing deficiencies. When
given intravenously, EDTA is 100 percent absorbed very rapidly and eliminated in the
urine within a few hours. Intravenous EDTA is given on only 20 to 30 days in any one
year and does not lead to deficiencies of nutritional minerals. Nutritional
supplementation on a daily basis more than compensates for any loses caused by the
intravenous EDTA chelation therapy.


                                        8 of 13
                                 7/6/2011 @8:47 PM
No! Before recent medical breakthroughs in the area of free radical pathology, it was
hypothesized that EDTA chelation therapy had its major beneficial effect on calcium
metabolism—that it stripped away the excess calcium from the plaque, restoring
arteries to their pliable precalcified state. This frequently offered explanation—the so-
called "roto-rooter" concept—is not the real reason, as previously postulated, that
chelation therapy produces its major health benefits. The fact that EDTA does reduce
some calcium from plaque is felt to be only one of its benefits, an probably not the
mos important. Nonetheless, calcium does play a role and is one reason why the use
of calcium EDTA is not recommended. Calcium EDTA has no beneficial effect on
calcium deposits in the body.

Most importantly, EDTA has an affinity for the transition metal, iron, a free radical
catalyst in excess, and for the toxic metals, lead, mercury, cadmium, nickel, and
aluminum. Free radical pathology, it is now believed, is an important underlying
process triggering the development of many age-related ailments, including cancer,
senility and arthritis, as well as atherosclerosis. Thus, EDTA’s most important benefit
seems to be that it greatly reduces the ongoing production of free radicals within the
body by removing accumulations of metallic catalysts and toxins which accumulate at
abnormal sites in the body as a person grows older and which speed the aging process.
There are other theories of mechanism of action and we still do not know which is
most important. Recent research even points to rebalancing toxic accumulations of
essential elements such a zinc, chromium and cobalt.

For readers with a decided interest in the scientific technicalities you can refer to the
article entitled Scientific Rational for EDTA Chelation Therapy: Mechanism of
Action by Elmer M. Cranton, M.D. and James P. Frackelton, M.D.

For a fuller explanation of the many issues involved, you will enjoy reading
BYPASSING BYPASS SURGERY, a full- length book by Elmer M. Cranton, M.D.,
which is written in popular form for the general public. The article on the scientific
rationale and mechanism of action, mentioned in the last paragraph, is also contained
as a chapter in that book under the heading, "Take This to Your Doctor."


Because the very aging process itself correlates with ongoing free radical damage, it is
no surprise that a large variety of symptoms have been reported to improve following
chelation therapy, even symptoms not directly caused by circulatory disease. While
there is no scientific evidence that chelation is a cure for these diseases, symptoms of
arthritis, Alzheimer’s, Parkinson’s , psoriasis, high blood pressure, and scleroderma
have all been reported to improve with chelation therapy. In fact, there is no better
treatment for scleroderma. Vision has been improved in macular degene ration.
Patients generally feel younger and more energetic following therapy, even when
taken for purely preventive reasons. In fact, chelation therapy is more desirable for
prevention that it is for established disease. Preventive medicine is always prefe rable
to late stage crisis intervention.

A recently published article from the University of Zurich in Switzerland reported an
18-year follow-up of a group of 56 chelation therapy patients. When comparing the
death rate from cancer with that of a control group of patients who did not receive

                                         9 of 13
                                  7/6/2011 @8:47 PM
chelation therapy, the authors found that patients who received EDTA chelation
therapy had a 90% reduction of cancer deaths. Epidemiologists from the University of
Zurich reviewed the data and found no fault with the reported facts or the conclusions.

There is no evidence that chelation therapy is of benefit in the treatment of advanced
cancer, once the diagnosis is made, but there is a large body of scientific research
indicating that free radical damage to DNA is an important factor at the onset of most
cancer. Chelation therapy blocks damaging free radicals.

Will chelation therapy help with heart valve problems such as aortic stenosis or
mitral regurgitation?

EDTA chelation will not have much effect on diseased heart valves as such. However,
chelation has been shown to improve the efficiency of cardiac function and relieve
symptoms and reduce probability of heart attack and other complications. If surgical
replacement of the valve becomes necessary, prior chelation therapy should speed
recovery and reduce the probability of serious surgical complications such as stroke or
myocardial infarction ( heart attack).


If EDTA chelation therapy is safe and effective as indicated by many published
studies, and by the experience of hundreds of doctors, why haven’t you heard more
about it? That is a good question!

Until quite recently, relatively few patients have been informed that this therapy is
available. Many heart specialists may not have even heard of the treatment and would
be reluctant to prescribe it if they had. The American Medical Association has not yet
approved chelation therapy for atherosclerosis, although it does endorse its use in the
treatment of lead poisoning. Many insurance companies will not compensate policy
holders for chelation therapy unless it is given for proven lead poisoning of a serious
degree. If chelation therapy is given for atherosclerosis, it is often labeled
"experimental" or "not necessary " or "not customary" by medical insurance
companies and payment is denied. They deny payment to patients for chelation
therapy even though they do pay for bypass surgery, and even though chelation might
have saved them tens of thousands of dollars. Like many other aspects of our lives, a
considerable amount of politics seems to be involved—in this case, medical politics.

Politically powerful traditional medical groups and manufacturers of cardiovascular
drugs have consistently suppressed knowledge of chelation therapy, perhaps because
of a large vested interest in competing coronary related health care. The cost of all
medical care for victims of heart disease in the United States, including coronary
bypass surgery and prescription drugs, exceeds $50 billion per year. Obviously, many
hospitals, physicians, and pharmaceutical companies would experience a decline in
need for their services if chelation therapy were to become universally popular.

Physicians who remain skeptical about chelation therapy are those who have never
used it. They are either completely uninformed about the research that has been done
to document the safety and effectiveness of chelation therapy, or they are committed
by training or source of income to other therapeutic procedures, such as vascular

                                       10 of 13
                                 7/6/2011 @8:47 PM
surgery and related procedures. Many physicians have merely accepted criticisms of
an editorial nature stemming from such sources, without digging into the true facts for
themselves. Recent reports of clinical trails alleging to disprove chelation therapy are
all so flawed in design that they offer no evidence at all. Doctors, however, are
usually too busy to read every word, and often accept the misleading summaries and
abstracts, without analyzing the data for themselves. The bypass and cardiovascular
drug industries have been extremely well marketed—to the medical profession as well
as to the public.

does EDTA EFFECT metal IN stents and joint replacements?

EDTA has no effect on intact metals used for implants in the body, or anywhere else
for that matter. EDTA binds only dissolved and positively charged (oxidized) metal
ions dissolved in solution. Stents and joint replacement are made from alloys such as
highly refined stainless steel, vanadium alloys and titanium, that will not dissolve in
body fluids


It is a myth that heavy metal toxicity is an important cause of age-related diseases
such as atherosclerosis and heart disease. Dr. Cranton has tested hundreds chelation
patients for levels of toxic metal levels. Although small amounts are present in
virtually everyone, levels have only very rarely been found to be in the toxic range.
Although laboratories used by some chelation clinics tend to exaggerate the toxic
potential of such low levels, we still do not know how EDTA chelation therapy brings
its benefits.


Your lifestyle counts. Chelation therapy is only part of the curative process. Improved
nutrition and healthy lifestyle are absolutely imperative for lasting benefit from
chelation treatments. Chelation is not in and of itself a "cure-all"—it reduces
abnormal free radical activity and removes unwanted and toxic metals, allowing
normal healing and control mechanisms to come in to play. It has many actions in the
body and we do not yet know what is the most important. Healing is facilitated,
allowing health to be restored with the help of applied clinical nutrition, antioxidant
supplementation and improved lifestyle. A full program of chelation therapy involves
all of these factors. Chelation therapy is also compatible with other forms of therapy,
including bypass surgery if all else fails. If cardiovascular drugs are needed, they can
be taken with chelation with no conflict.

In addition to receiving the recommended number of chelation treatments, patie nts
eager for long-term benefits should follow a healthy lifestyle, take a spectrum of
nutritional supplements, be physically active and eliminate destructive lifestyle habits
such as tobacco and excessive alcohol.


Hyperbaric oxygen treatment (HBO) involves treatment of the entire body in a small

                                       11 of 13
                                 7/6/2011 @8:47 PM
chamber totally immersed in 100 percent oxygen, at pressures greater than the normal
atmosphere. HBO stimulates new blood flow, and keeps organs alive and functioning,
even when they are deprived of adequate blood flow. HBO also helps fight infection.
HBO is especially helpful in cases of gangrenous or pre-gangrenous feet, to speed
healing while the slower process of chelation has time to work, and to restore brain
function following a stroke. Many patients receive hyperbaric oxygen treatments on
the same day that they receive chelation for the added benefits of the two types of


A scientifically balanced regimen of nutritional supplements reinforces the body’s
antioxidant defenses and should include vitamins E, C, B1, B2 B3, B6, B12, PABA,
beta carotene, and coenzyme Q10, and others. A balanced program of mineral and
trace element supplementation should also include calcium, magnesium, zinc, copper,
selenium, manganese, vanadium, and chromium. Dr. Cranton's Prime Nutrients™, the
best high-potency multiple vitamin, mineral, trace element formula, provides a
balanced foundation supplement, all in one bottle and at reasonable cost. Dr.
Cranton's AntioxPackets provide a much more complete regimen at additional cost ,
and are especially indicated for symptomatic and elderly patients. Chelation patients
are routinely placed on the AntioxPackets™, one twice daily with meals. That is what
Dr. Cranton and his family take.


It is important to eliminate the use of tobacco. This applies to cigarettes, pipe tobacco,
cigars, snuff or chewing tobacco. It has been a consistent observation that patients
who continued to use tobacco following chelation will experie nce comparatively less
improvement and for a shorter time.

Relatively healthy adults are often able to tolerate the moderate use of alcoholic
beverages without generating more free radicals than they can detoxify. Anyone who
drinks alcoholic beverages excessively risks harmful free radical damage. Victims of
chronic degenerative diseases should minimize the consumption of alcohol.


Finally, physical exercise is very helpful. Even a brisk 30-minute walk several times
per week will help to maintain the health benefits and improved circulation resulting
from chelation therapy. Lactate normally builds up in tissues during aerobic exercise,
and lactate is a natural chelator produced within the body. Which brings us to the final


Only you can make that decision!

Chances are, your doctor won’t help you decide. Patients who choose chelation
therapy often do so against the advice of their personal physicians or cardiologists.

                                        12 of 13
                                  7/6/2011 @8:47 PM
Many have already been advised to undergo vascular surgery. Occasionally, a patient
never hears about chelation therapy until he or she is hospitalized and a friend or
relative begs him or her to look into this non- invasive therapy before proceeding to
surgery. In an impressively large number of instances, a ne w patient comes for
chelation on the recommendation of someone who has been successfully chelated.
Many patients have benefited even after one or more failed bypasses.

You are encouraged to communicate with someone who’s shared your dilemma,
someone who can tell you about his or her own experience with chelation therapy.
Feel free to contact others with problems similar to yours who have chosen chelation
therapy. Most patients who have been helped will be happy to give you their side of
the story.

                                      13 of 13
                                7/6/2011 @8:47 PM

To top